Avoid injecting into veins or muscles semaglutide should be injected into the tissue under the skin
On Monday, a pharmaceutical company ended a direct sale deal offering Wegovy at a discount through the Hims & Hers telehealth company
That steadiness supports more predictable appetite suppression and blood sugar regulation
In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect
Understanding that semaglutide must be injected subcutaneouslynot intramuscularly or intradermallyis fundamental to achieving optimal therapeutic outcomes and minimizing adverse effects
[4] Concerning symptoms that should trigger medical review include: Severe or persistent abdominal pain, which could indicate pancreatitis (a rare but serious adverse effect)seek urgent medical help via NHS 111, 999, or A&E as appropriate [2] [3] Signs of hypoglycaemia (if taking Ozempic with insulin or sulphonylureas) Unexplained weight gain or inability to lose weight despite dietary adherence New or worsening visual symptoms, especially if you have pre-existing diabetic retinopathy Right upper abdominal pain, fever or jaundice, which could indicate gallbladder problems [2] [3] Medication review is important if you are taking other drugs that may affect appetite or interact with Ozempic